Excerpt: During the past month, we have heard from a number of concerned citizens, including parents, law enforcement officials, health care providers, state and local officials, and our colleagues in Congress, about the impending release of the non-tamper-resistant versions of these opioids. According to these concerned citizens, the release of the non-tamper-resistant versions will deal a significant setback to our nation’s ongoing struggle to stop prescription drug abuse.
Excerpt: Since the October 6, 2011, letter, Beacon Power and Abound Solar declared bankruptcy, making them the second and third recipients of a Section 1705 loan guarantee to do so. Recent reports have indicated that several other recipients remain in unstable financial condition. The Committee is determined to continue its oversight of this program and ensure that taxpayer interests are prioritized.
Excerpt: As the Obama administration and Congress debate the best way to address the upcoming fiscal cliff, it is impossible to ignore the role of entitlement spending as we work to strengthen our economy and put our nation on a strong fiscal path. With a $16 trillion debt and four straight years of more than trillion dollar deficits, it’s time to acknowledge that entitlement programs are the biggest contributors to federal spending and current budget deficits. This is not a discussion that
Excerpt: In recent weeks, questions have been raised in Congress and among public interest groups about the use of one or more secondary email accounts and aliases by you and potentially other officials at the Environmental Protection Agency. Given your reported use of at least one alias email account in your conduct of agency business, we write to ask that you describe fully the nature and extent of this practice.
Excerpt: Our offices have learned that UnitedHealth Group, through its subsidiary, Optum, purchased QSSI in late September 2012. UnitedHealth Group now owns both Optum and QSSI; it also owns UnitedHealth, a major national provider of health care plans and competitor to offer health plans expected to particpate in a federal exchange.
Excerpt: Allegations that your association may have encouraged compounding pharmacists to attempt to impede FDA from evaluating the efficacy and safety of their products, if true, raise serious concerns about your actions.
To read the letter, click here.